Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Impact of the integration of remote clinical oncology pharmacists into routine precision medicine workflows on biomarker testing rates within The US Oncology Network community-based practices.

View Full Paper
Ask AI
Bookmark
Share

Authors

NGNatalie GreislBHBrittney HaleMCMelissa Carroll

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Greisl et al. (2024) studied this question.

synapsesocial.com/papers/68e673edb6db6435875fe232https://doi.org/10.1200/jco.2024.42.16_suppl.e13813
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network’s MYLUNG Consortium2024
  2. 2A quality improvement initiative to improve genomic testing rates in patients with prostate cancer.2026
  3. 3Clinical impact and financial feasibility of remote oncology pharmacists' roles in community oncology practices.2024
  4. 4Effect of clinical decision support integration on biomarker testing adherence, care quality, and costs in community oncology: A multi-stakeholder initiative.2025
  5. 5Understanding gaps in molecular testing practices for metastatic prostate cancer (mPC): A statewide quality improvement initiative.2025